Reflecting on a Year of Meaningful Innovations
Dermatology Times
NOVEMBER 14, 2023
2023 has been complete with numerous innovations in the dermatology space, including in atopic dermatitis, psoriasis, alopecia areata, and more.
Improving Care and Innovations in Vitiligo and Atopic Dermatitis: Part 1
Dermatology Times
NOVEMBER 18, 2024
In a Dermatology Times Case-Based Peer Perspective event, Terry Faleye, MPAS, PA-C, reviewed 2 cases of patients with vitiligo to discuss innovative treatments and emotional challenges with disease management.
Innovations 
73
73 
Peter Lio, MD: Delving Into Disease Progression in Pediatric Atopic Dermatitis
Dermatology Times
JULY 13, 2024
Lio discusses his SPD 2024 non-CME talk, new and exciting innovations in pediatric atopic dermatitis, and more.
Dermatitis 78
78 
JNJ Continues to Grow AD Pipeline With New Licensing Agreement
The Dermatology Digest
DECEMBER 27, 2024
Johnson & Johnson has entered into an exclusive licensing agreement for the global development, manufacturing and commercialization of a STAT6 program for autoimmune and allergic diseases, including atopic dermatitis (AD), from Kaken Pharmaceutical. the venture capital organization of Johnson & Johnson.
Dermatitis 36
36 
Silver Linings With the Silverbergs: Showcasing Vitiligo and Atopic Dermatitis Research
Dermatology Times
JANUARY 11, 2024
Innovative practice pearls for both vitiligo and atopic dermatitis treatment were shared with nearly 200 clinicians to put into practice at the virtual Revolutionizing Vitiligo and Revolutionizing Atopic Dermatitis Conferences.
Dermatitis 74
74 
ResVita Bio Awarded NIAID Grant for Atopic Dermatitis Research
Dermatology Times
SEPTEMBER 18, 2023
The Small Business Innovation Research grant enables ResVita Bio to develop RVB-101 for treatment of severe atopic dermatitis.
Dermatitis 72
72 
Oh, What a Year! The Skin of Color Society Reflects on Its Dynamic 2024
The Dermatology Digest
DECEMBER 30, 2024
While educating the public about the common and often bothersome condition known as winter skin, which affects people of all ages, skin types and tones, funds raised through this campaign go to the SOCS Foundation to help support innovative research, education, mentorship and advocacy in skin of color dermatology.
Webinar 78
78 
Researchers Close In on New Topical Therapy That Suppresses Mast Cells
The Dermatology Digest
DECEMBER 11, 2024
Through the Pitt Office of Innovation and Entrepreneurships Innovation Institute, they have also applied for a patent for the use of SYM2081 to suppress mast cell function.
Therapy 41
41 
Dr. Michael Schön Joins Scinai Immunotherapeutics’ Scientific Advisory Board
The Dermatology Digest
DECEMBER 5, 2024
“It is a great pleasure and honor for me to be part of the advisory board for Scinai and to contribute to the success of their highly innovative pipeline,” he says in a news release. “In Schön, a world-class expert in dermatology, particularly in psoriasis and atopic dermatitis, to our Scientific Advisory Board.
Innovations 36
36 
Dr. Emma Guttman-Yassky Receives the ASA’s First-ever Therapeutic Innovation Award
The Dermatology Digest
APRIL 5, 2024
Emma Guttman-Yassky, MD, PhD, received the first-ever Therapeutic Innovation Award from the American Skin Association (ASA) for her work in helping to unravel the molecular and cellular mechanisms driving inflammatory skin diseases including atopic dermatitis (AD). School of Public Health.
Innovations 50
50 
Done Deal: Organon Completes Acquisition of Dermavant
The Dermatology Digest
OCTOBER 28, 2024
The FDA is reviewing a supplemental New Drug Application (sNDA) for tapinarof cream, 1%, as a potential treatment for atopic dermatitis (AD) in adults and children two years of age and older, with Prescription Drug User Fee Act (PDUFA) action expected in the fourth quarter of calendar year 2024.
Portfolios 36
36 
Arcutis’ Zoryve Foam Is Now Available for Seb Derm Treatment in the U.S.
The Dermatology Digest
JANUARY 22, 2024
s ZORYVE topical foam, 0.3%, is now officially available for the treatment of seborrheic dermatitis. Food and Drug Administration (FDA) approved ZORYVE foam for the treatment of seborrheic dermatitis in individuals 9 years of age and older on December 15, 2023. Arcutis Biotherapeutics, Inc.’s
Dermatitis 78
78 
Unveiling the Complexities of Atopic Dermatitis Care
Dermatology Times
JANUARY 8, 2025
Experts explore innovative therapies, psychosocial impacts, and education strategies for managing atopic dermatitis in a Dermatology Times video series.
Dermatitis 41
41 
Galderma’s Nemolizumab Approved for AD and PN in the UK and Switzerland
The Dermatology Digest
FEBRUARY 18, 2025
Just days after snagging dual approvals for moderate-to-severe atopic dermatitis (AD) and prurigo nodularis (PN) in the European Union, nemolizumab (Nemluvio, Galderma) was also granted Marketing Authorization in the United Kingdom (UK) and Switzerland for AD and PN.
Dermatitis 36
36 
Almirall, Centre for Genomic Regulation Partner to Identify Molecular Pathways and Biomarkers for Atopic Dermatitis Treatments
Dermatology Times
FEBRUARY 8, 2024
The partnership is focused on exploring innovative therapeutic strategies to address AD.
Partnerships 74
74 
Type 2 Inflammation: Key Factor in Three Common Skin Conditions
The Dermatology Digest
APRIL 1, 2025
We have seen immense therapeutic innovation in the treatment of AD, PN, and chronic CSU, over the past decade, the reviews first author Raj Chovatiya, MD, PhD, MSCI,Founder and Director of the Center for Medical Dermatology + Immunology Research in Chicago,tells The Dermatology Digest.
Dermatitis 36
36 
FDA, EMA Accept Galderma’s BLA for Nemolizumab for PN and AD
The Dermatology Digest
FEBRUARY 14, 2024
Food and Drug Administration (FDA) has accepted Galderma’s Biologics License Applications for nemolizumab for the treatment of patients with prurigo nodularis (PN) and for adolescents and adults with moderate to severe atopic dermatitis (AD). Galderma is planning for multiple regulatory submissions in 2024.
Dermatitis 78
78 
Advancements in Atopic Dermatitis: Insights from the 2024 Masterclasses in Dermatology Conference
Dermatology Times
DECEMBER 18, 2023
Raj Chovatiya, MD, PhD introduces a video series program exploring cutting-edge treatments at the forefront of atopic dermatitis management, exploring innovative insights and research that will redefine dermatological care.
Dermatitis 36
36 
Future Perspectives: Can Innovative Topical Therapies Like Ruxolitinib Reduce Systemic Treatment Dependency in Pediatric AD?
Dermatology Times
APRIL 18, 2025
James Song, MD, FAAD, discusses how emerging topical JAK inhibitors like ruxolitinib cream may reduce the necessity for systemic therapies in select pediatric atopic dermatitis patients by effectively controlling moderate disease and potentially serving as long-term maintenance therapy with a favorable safety profile.
Therapy 36
36 
Mount Sinai Awarded $6.6M NIH Grant to Study Dupilumab in Pediatric AA
The Dermatology Digest
MAY 16, 2024
This funding will enable us to embark on a transformative journey, pushing the boundaries of alopecia research and paving the way for innovative solutions to this burdensome disease.” Among children with alopecia areata, 33% have atopic dermatitis, 21% have asthma, 20% have hay fever, and 14% have another type of allergy.”.
Eczema 69
69 
Matthew Zirwas, MD: Cutting-Edge Advances in Atopic Dermatitis and Itch Management
Dermatology Times
NOVEMBER 14, 2024
Zirwas presented 2 sessions at SDPA on innovative care strategies for patients with AD and other itch-related diseases.
Management 36
36 
Understanding and Treating Pediatric AD Inside and Out
Dermatology Times
MARCH 4, 2025
Experts discussed pediatric atopic dermatitis, treatment innovations, disease burden, and the latest topical and systemic therapies in a DermView video series.
Dermatitis 36
36 
Celebrating Advancements in AD With Topical Creams
Dermatology Times
JANUARY 13, 2025
A panelist discusses how recent innovations in topical cream formulations for atopic dermatitis have led to improved efficacy, better tolerability, and enhanced quality of life for patients.
Dermatitis 36
36 
Drug-delivering Microneedle Patch May Spur Hair Regrowth in AA
The Dermatology Digest
MAY 9, 2024
This strategy could also be adapted to treat other autoimmune skin diseases such as vitiligo, atopic dermatitis, and psoriasis, the researchers note. This innovative approach marks a paradigm shift.
FDA Clears IND Application for InnoCare’s TYK2 Inhibitor
The Dermatology Digest
JUNE 14, 2024
Food and Drug Administration (FDA) has cleared InnoCare Pharma’s investigational new drug application (IND) for ICP-332, a tyrosine kinase 2 (TYK2) inhibitor that’s being studied in moderate to severe atopic dermatitis (AD). Currently, no TYK2 inhibitors have obtained marketing approval for the treatment of AD.
Dermatitis 36
36 
TDD Editorial Advisory Board Member Dr. Emma Guttman-Yassky Recieves High Honor at EAACI Meeting
The Dermatology Digest
JUNE 4, 2024
Dr. Guttman has dedicated her clinical and research careers to inflammatory skin diseases, focusing on atopic dermatitis (AD)/eczema and recently also alopecia areata, as well as rare skin diseases that, until her research studies, did not have any treatments.
Eczema 36
36 
Business News: Organon to Buy Dermavant including Tapinarof Cream, 1%(Vtama)
The Dermatology Digest
SEPTEMBER 18, 2024
The FDA is reviewing a Supplemental New Drug Application (sNDA) for tapinarof cream, 1% as a potential treatment for atopic dermatitis (AD) in adults and children two years of age and older, with Prescription Drug User Fee Act (“PDUFA”) action expected in the fourth quarter of calendar year 2024.
Dermatitis 36
36 
Meet the 2023 NEA Grant Winners
The Dermatology Digest
DECEMBER 14, 2023
The 2023 research grantees include: The Champion Research Grant encourages researchers to continue research on emerging or ongoing challenges in eczema or bring their expertise to the field of eczema. in subsequent National Institutes of Health (NIH) funding to support further research.
Eczema 36
36 
Clinique, Icahn School of Medicine at Mount Sinai Join Forces to Establish the Mount Sinai-Clinique Healthy Skin Dermatology Center
The Dermatology Digest
FEBRUARY 2, 2024
The partnership will focus on applicable scientific discovery and innovation to modernize allergy science to identify innovative solutions for these skin conditions. Additionally, this research will inform and inspire Clinique in future product innovation to offer further solutions for people with allergic or sensitive skin.
Dermatology 36
36 
Global Launch of 2 All-New Cold Plasma Devices for Skin + Hair
Lipgloss and Aftershave
JUNE 12, 2024
Whether you’re a long-time JET provider or a newcomer, prepare to be amazed by the innovation and dedication that have gone into making this next chapter their most exciting yet. The new features are designed to be intuitive, powerful, and incredibly useful, empowering you to achieve more with less effort. seconds with the original JET.
Esthetics 52
52 
Clean beauty, oil cleansing and more – episode 194
The Beauty Brains
SEPTEMBER 20, 2019
How should you treat seborrheic dermatitis? I have low porosity curly hair but my scalp suffers from chronic seborrheic dermatitis. Can you shed some light on whether or not there is any truth to these claims with new and innovative products? What do you think of the Active Beauty products? Special guest brain, Sarah Bellum!
Social Media 40
40 
Treating AD in Kids: The Dawn of a New Day
The Dermatology Digest
JANUARY 30, 2024
Lawrence Eichenfield, MD, Chief of Pediatric and Adolescent Dermatology at Rady Children’s Hospital-San Diego and Professor of Dermatology and Pediatrics and Vice-chair of the Department of Dermatology at UC San Diego School of Medicine, discusses innovations in topical and systemic therapies for atopic dermatitis in kids.
Hospital 28
28 
And the Winners Are…PeDRA Announces 2023 Grant Recipients
The Dermatology Digest
JANUARY 30, 2024
2023 Childhood Eczema Challenge Grant – Supported in partnership with the National Eczema Association (NEA) Hassan Vahidnezhad, MSc, PhD of Children’s Hospital of Philadelphia, will conduct a project titled “ Genetic Landscape of Pediatric Patients with Monogenic Susceptibilities to Atopic Dermatitis.
Partnerships 36
36 
Cannabinoids for the Treatment of Dermatologic Conditions
First Derm
OCTOBER 14, 2023
Unlocking the Potential: How Cannabinoids Transform Dermatologic Care In the realm of dermatology, cannabinoids have emerged as a beacon of hope, offering innovative solutions for a spectrum of skin conditions. Atopic Dermatitis Atopic dermatitis , a canvas often marred by itching and inflammation, has witnessed a renaissance.
Dermatology 40
40 
OTC Skincare: How Much Do You Know?
The Dermatology Digest
AUGUST 9, 2023
Cosmetic companies that once focused on moisturizers, cleansers, and sunscreens are now innovating and creating effective treatments for conditions such as acne, rosacea, atopic dermatitis, psoriasis, seborrhea, hyperpigmentation, and anti-aging.
Skincare 36
36 
Topline Phase 1 Trial Results for Apogee’s APG777 in AD “Exceed Expectations”
The Dermatology Digest
MARCH 5, 2024
Pharmacokinetic (PK) data showed a half-life of approximately 75 days across doses tested and pharmacodynamic (PD) data showed, deep and sustained inhibition of key atopic dermatitis (AD) biomarkers pSTAT6 and TARC for ~3 months (longest follow-up available, with inhibition still ongoing at time of the data cut).
Injections 36
36 
Oxymel to Fight Asthma, Inflammation, and Obesity
Aesthetics Advisor
AUGUST 22, 2023
A review article in Frontiers of Immunology describes the effects of honey and its natural power to strengthen the immune system, as well as to counteract allergic diseases, including anaphylaxis, asthma, and atopic dermatitis. Reposted from: [link]
Extractions 36
36 
Are Micellar Water makeup removers the real deal? Episode 150
The Beauty Brains
SEPTEMBER 12, 2016
Beauty Science News Self-cleaning hair brush Link Here’s an innovation that I think is very cool – a self cleaning hairbrush. Scientists believe that it is a proven effective treatment for atopic dermatitis. Polymers do the same thing but provide more hold less grit. PVP or ones that start with PVP/VA).
Makeup 52
52 
Biggest Skin-Care Trends of 2024 - Allure
Aesthetics Advisor
JUNE 16, 2024
Exosomes, neurocosmetics, and supercharged actives are the most innovative — and sometimes the most controversial — skin-care trends poised to revolutionize beauty in the next few years. This can make skin drier and, over time, more vulnerable to conditions like dermatitis. Regenerative medicine will inspire your skin care.
Injections 36
36 
Ingredients Demystified: Anti-Aging Meets Acne-Safe
Lipgloss and Aftershave
NOVEMBER 15, 2023
EpiStep Needle-Free Needling EpiStep is a family of innovative products and devices that offers Skin Care Professionals various steps to improve the epidermis. Comprehensive training and compliance to the scope of practice are and will always be important to us and therefore part of our products and services.
Ingredients 97
97 
Benefits of Oil Cleansing: A Holistic Approach to Radiant Skin
Enlightened Beauty
SEPTEMBER 22, 2023
In the realm of skincare, there's a delicate balance between tradition and innovation. An oil cleanser for acne, dermatitis, and rosacea? Ease Contact Dermatitis: If you've ever experienced the itchiness and discomfort of contact dermatitis, this oil cleanser can be your soothing balm. And the best part?
Sebum 52
52 
Get to Know Alys Pharmaceuticals, Inc.
The Dermatology Digest
FEBRUARY 12, 2024
Alys believes that emerging indications such as atopic dermatitis, vitiligo, alopecia areata and chronic spontaneous urticaria, will see the next breakthroughs in dermatological advancements.
Can Niacinamide transform natural killer cells into a cancer therapy? Scientists think the answer is yes
Aesthetics Advisor
OCTOBER 3, 2023
The innovative approach boosted the impact of natural killer cells and brought about remissions in patients with otherwise recalcitrant cancers. The disorder is typified by the three D's—dementia, diarrhea and dermatitis. Without treatment, which is simply providing niacin, pellegra can be fatal.
Therapy 36
36 
Oh, The Places Dermatology Will Go in 2024!
The Dermatology Digest
FEBRUARY 8, 2024
In 2023, dermatologists and their patients welcomed new drugs for acne, psoriasis, alopecia areata, and more, and 2024 promises to deliver real-world data on these medications along with even more therapeutic innovations across the spectrum of cutaneous diseases. Taking Seb Derm Seriously The U.S.
Dermatology 78
78 
Let's personalize your content